CoChat

A novel molecular disease classifier for psoriasis and eczema

Garzorz‐Stark, Natalie, Krause, Linda, Lauffer, Felix, Atenhan, Anne, Thomas, Jenny, Stark, Sebastian P., Franz, Regina, Weidinger, Stephan, Balato, Anna, Mueller, Nikola S., Theis, Fabian J., Ring, Johannes, Schmidt‐Weber, Carsten B., Biedermann, Tilo, Eyerich, Stefanie, Eyerich, Kilian · 2016 · Experimental Dermatology
Cited by 79

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Novel specific therapies for psoriasis and eczema have been developed, and they mark a new era in the treatment of these complex inflammatory skin diseases. However, within their broad clinical spectrum, psoriasis and eczema phenotypes overlap making an accurate diagnosis impossible in special cases, not to speak about predicting the clinical outcome of an individual patient. Here, we present a novel robust molecular classifier ( MC ) consisting of NOS 2 and CCL 27 gene that diagnosed psoriasis and eczema with a sensitivity and specificity of >95% in a cohort of 129 patients suffering from (i) classical forms; (ii) subtypes; and (iii) clinically and histologically indistinct variants of psoriasis and eczema. NOS 2 and CCL 27 correlated with clinical and histological hallmarks of psoriasis and eczema in a mutually antagonistic way, thus highlighting their biological relevance. In line with this, the MC could be transferred to the level of immunofluorescence stainings for iNOS and CCL 27 protein on paraffin‐embedded sections, where patients were diagnosed with sensitivity and specificity >88%. Our MC proved superiority over current gold standard methods to distinguish psoriasis and eczema and may therefore build the basis for molecular diagnosis of chronic inflammatory skin diseases required to establish personalized medicine in the field.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/exd.13077

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 79

Metadata

Authors
Garzorz‐Stark, N., Krause, L., Lauffer, F., Atenhan, A., Thomas, J., Stark, S. P., Franz, R., Weidinger, S., Balato, A., Mueller, N. S., Theis, F. J., Ring, J., Schmidt‐Weber, C. B., Biedermann, T., Eyerich, S., & Eyerich, K.
Venue
Experimental Dermatology
Publisher
Wiley
Published
2016-09-29
Volume
25
Issue
10
Pages
767-774
ISSN
  • 0906-6705 (ISSN-L)
  • 1600-0625
OpenAlex
W2404269503
Cited by
79
References
4
FWCI
3.20
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A novel molecular disease classifier for psoriasis and eczema. https://app.cochat.ai/papers/10.1111/exd.13077
The paper
Garzorz‐Stark, N., Krause, L., Lauffer, F., Atenhan, A., Thomas, J., Stark, S. P., Franz, R., Weidinger, S., Balato, A., Mueller, N. S., Theis, F. J., Ring, J., Schmidt‐Weber, C. B., Biedermann, T., Eyerich, S., & Eyerich, K. (2016). A novel molecular disease classifier for psoriasis and eczema. Experimental Dermatology. https://doi.org/10.1111/exd.13077

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.